New Data Reveal Molecular Drivers of Thyroid Eye Disease (TED) May Remain Activated In Patients with Low Clinical Activity Score (CAS)

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics announced new data on the key drivers of Thyroid Eye Disease (TED) at the American Academy of Ophthalmology (AAO) 2022.

Full Story →